Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Cytokinetics (CYTK) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 36 quarters since 2012. Compare with CYTK stock chart to see long term trends.

CYTK stock compared to

CYTK Income Statement

Revenue, Net:6722000
Revenue Per Share:104.18
Research & Development Expense:29221000
Total Operating Expenses:43129000
Operating Income:-36407000
Net Income:-43930000
Earnings Per Share, Basic:-0.58
Shares Outstanding, Basic Avg:64524

CYTK Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:471000
Change in Accounts Receiveable:-545000
Net Cash from Operations:52150000
Net Cash from Financing Activities:3641000
Property, Plant & Equipment Purchases:6555000
Net Cash from Investing Activities:-173618000
Net Change in Cash & Equivalents:-117827000

CYTK Balance Sheet

Cash and Cash Equivalents:501000000
Accounts Receivable, Net:4420000
Total Current Assets:474221000
Property, Plant & Equipment, Net:13346000
Total Assets:533803000
Accounts Payable:8050000
Total Short-Term Liabilities:31199000
Long Term Debt, Non-Current Portion:46209000
Total Liabilities:420420000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
10,759,951 sh
1,398,262 sh
15%
$232,952
$12,298
Vanguard Group Inc
4,964,324 sh
393,116 sh
9%
$107,479
-$264
FMR LLC
3,355,621 sh
-153,226 sh
-4%
$72,649
-$10,054
BVF Inc Il
3,323,051 sh
3,323,051 sh
NEW
$71,944
$71,944
Driehaus Capital Management LLC
3,031,698 sh
-77,674 sh
-2%
$65,636
-$7,652
Wellington Management Group Llp
2,940,539 sh
-71,081 sh
-2%
$63,663
-$7,322
Great Point Partners LLC
2,549,525 sh
1,028,890 sh
68%
$55,197
$19,356
Farallon Capital Management LLC
2,150,000 sh
650,000 sh
43%
$46,548
$11,193
Goldman Sachs Group Inc
898,831 sh
84,192 sh
10%
$19,459
$258
Northern Trust Corp
877,936 sh
82,571 sh
10%
$19,006
$259
Morgan Stanley
841,077 sh
136,290 sh
19%
$18,209
$1,597
Price T Rowe Associates Inc /Md/
660,154 sh
660,154 sh
NEW
$14,292
$14,292
Charles Schwab Investment Management Inc
448,851 sh
59,962 sh
15%
$9,718
$551
Invesco Ltd.
430,709 sh
-158,858 sh
-27%
$9,325
-$4,571
Ameriprise Financial Inc
312,623 sh
37,063 sh
13%
$6,767
$272
Bank Of America Corp /De/
280,816 sh
94,537 sh
51%
$6,080
$1,690
Great Point Partners LLC
Put options for 253,000 sh
253,000 sh
NEW
$5,477
$5,477
Legal & General Group Plc
199,744 sh
31,489 sh
19%
$4,324
$358
Prudential Financial Inc
133,605 sh
40,610 sh
44%
$2,892
$700
Credit Suisse Ag/
130,973 sh
45,982 sh
54%
$2,836
$833

Data imported from Cytokinetics Inc SEC filings. Check original filings before making any investment decision.